The aromatic ketone 4′-hydroxychalcone inhibits TNFα-induced NF-κB activation via proteasome inhibition
Authors:
- Deniz TasdemirDTDeniz Tasdemir
- Frantisek GolaisFGFrantisek Golais
- Mario DicatoMDMario Dicato
- Marc DiederichMDMarc Diederich
- 1 September 2011
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 82 (6) , 620-631
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- The role of chalcones in suppression of NF-κB-mediated inflammation and cancerInternational Immunopharmacology, 2011
- The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapyExpert Opinion on Therapeutic Targets, 2009
- Tumour necrosis factor and cancerNature Reviews Cancer, 2009
- The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptorsNature Immunology, 2008
- Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell GrowthJNCI: Journal of the National Cancer Institute, 2008
- Oncogenic Ras-Induced Expression of Cytokines: A New Target of Anti-Cancer TherapeuticsMolecular Interventions, 2008
- Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-κB pathwayBiochemical Pharmacology, 2008
- Inhibitory effect of naringenin chalcone on inflammatory changes in the interaction between adipocytes and macrophagesLife Sciences, 2007
- Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c‐IAP1 and c‐IAP2) in vitroFEBS Letters, 2004
- TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB PathwayJournal of Molecular Biology, 2003